Cargando…
Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
PURPOSE: In the present study, we screened a compound library containing 1,600 clinically used compounds with the aim to identify compounds, which potentially could be repositioned for colon cancer therapy. METHODS: Two established colon cancer cell lines were tested using the fluorometric microcult...
Autores principales: | Nygren, Peter, Fryknäs, Mårten, Ågerup, Bengt, Larsson, Rolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825534/ https://www.ncbi.nlm.nih.gov/pubmed/24135855 http://dx.doi.org/10.1007/s00432-013-1539-5 |
Ejemplares similares
-
Mebendazole is unique among tubulin-active drugs in activating the MEK–ERK pathway
por: Andersson, Claes R., et al.
Publicado: (2020) -
Mebendazole stimulates CD14+ myeloid cells to enhance T-cell activation and tumour cell killing
por: Rubin, Jenny, et al.
Publicado: (2018) -
Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition
por: Blom, Kristin, et al.
Publicado: (2019) -
Selective radiosensitization by nitazoxanide of quiescent clonogenic colon cancer tumour cells
por: Karlsson, Henning, et al.
Publicado: (2022) -
A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer
por: Mansoori, S., et al.
Publicado: (2021)